ALB
USDAlbemarle Corporation Common Stock
Цена в режиме реального времени
График цен
Ключевые показатели
Рыночные показатели
Открытие
$90.170
Максимум
$98.421
Минимум
$90.010
Объем
3.34M
Фундаментальные показатели компании
Рыночная капитализация
11.4B
Отрасль
Специальные химикаты
Страна
United States
Статистические данные торговли
Средний объем
3.76M
Биржа
NYQ
Валюта
USD
52-недельный диапазон
Отчет об анализе ИИ
Последнее обновление: 4 нояб. 2025 г.ALB Stock Analysis: Navigating Lithium Market Shifts for Short-Term Gains
Market Sentiment Check
ALB's recent news cycle tells a story of strategic reshuffling. The company's decision to sell controlling stakes in Ketjen and Eurecat for $660 million caught eyes across Wall Street. This move suggests Albemarle's sharpening focus on its core lithium business just as the market shows promising signs of growth. Industry reports point to expanding lithium demand across multiple sectors, a development that directly impacts ALB's primary business segment.
On the analyst front, opinions are split like a lithium atom. Rothschild & Co kicked off coverage with an optimistic Buy rating and $135 price target--nearly 40% above current levels. Yet Bank of America Securities recently downgraded the stock to Neutral while paradoxically raising their price target to
Связанные новости
RBC Capital Maintains Outperform on Albemarle, Raises Price Target to $120
RBC Capital analyst Arun Viswanathan maintains Albemarle with a Outperform and raises the price target from $117 to $120.
Robust Growth Expected for Lithium Market as Demand Jumps Across Several Industries
MarketNewsUpdates News Commentary NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) -- A recent report in October 2025 from Market Research Future Analysis, said that: "As per MRFR analysis, the Lithium Market Size was
Albemarle Announces Quarterly Common Stock Dividend
The Board of Directors of Albemarle Corp. (NYSE: ALB) announced today that it declared a quarterly common stock dividend of $0.405 per share. The...
Albemarle to divest Ketjen control, Eurecat stake in $660 mln deal
Albemarle said on Monday it will sell a 51% stake in its refining catalyst solutions business, Ketjen, to private equity firm KPS Capital Partners, and divest its 50% interest in the Eurecat joint venture to France's Axens SA, in deals worth about $660 million.
KPS CAPITAL PARTNERS TO ACQUIRE CONTROLLING STAKE IN KETJEN FROM ALBEMARLE
KPS Capital Partners, LP ("KPS") announced today that, through a newly formed affiliate, it has entered into a definitive agreement with Albemarle...
Albemarle Announces Sale of a Controlling Stake in Ketjen to KPS Capital Partners
Albemarle Corporation (NYSE: ALB), a global leader in providing essential elements for mobility, energy, connectivity and health today announced it...
Rothschild & Co Initiates Coverage On Albemarle with Buy Rating, Announces Price Target of $135
Rothschild & Co analyst Mazahir Mammadli initiates coverage on Albemarle with a Buy rating and announces Price Target of $135.
Прогноз ИИBeta
Рекомендация ИИ
Обновлено в: 10 нояб. 2025 г., 15:29
62.1% Уверенность
Риск и торговля
Точка входа
$96.54
Взять прибыль
$99.13
Остановить убытки
$87.47
Ключевые факторы
Связанные акции
Оставаться в курсе
Установите ценовой сигнал, получите обновления анализа ИИ и новости рынка в режиме реального времени.